Assessment of 21-[18F]Huoro-16α-Ethyl-19-Norprogesterone as a Positron-Emitting Radiopharmaceutical for the Detection of Progestin Receptors in Human Breast Carcinomas

Farrokh Dehdashti; Andrea H. McGuire; Henry F. Van Brocklin; Barry A. Siegel; Dorothy P. Andriole; Landis K. Griffeth; Martin G. Pomper; John A. Katzenellenbogen; Michael J. Welch

Research ArticleHuman Studies

Assessment of 21-[¹⁸F]Huoro-16α-Ethyl-19-Norprogesterone as a Positron-Emitting Radiopharmaceutical for the Detection of Progestin Receptors in Human Breast Carcinomas

Farrokh Dehdashti, Andrea H. McGuire, Henry F. Van Brocklin, Barry A. Siegel, Dorothy P. Andriole, Landis K. Griffeth, Martin G. Pomper, John A. Katzenellenbogen and Michael J. Welch

Journal of Nuclear Medicine August 1991, 32 (8) 1532-1537;

Farrokh Dehdashti

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Andrea H. McGuire

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Henry F. Van Brocklin

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Barry A. Siegel

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Dorothy P. Andriole

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Landis K. Griffeth

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Martin G. Pomper

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

John A. Katzenellenbogen

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Michael J. Welch

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Info & Metrics
PDF

This is a PDF-only article. The first page of the PDF of this article appears above.

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 32, Issue 8

August 1, 1991

Table of Contents
Table of Contents (PDF)
Index by author
Advertising (PDF)
Ed Board (PDF)
Front Matter (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Assessment of 21-[18F]Huoro-16α-Ethyl-19-Norprogesterone as a Positron-Emitting Radiopharmaceutical for the Detection of Progestin Receptors in Human Breast Carcinomas

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Assessment of 21-[¹⁸F]Huoro-16α-Ethyl-19-Norprogesterone as a Positron-Emitting Radiopharmaceutical for the Detection of Progestin Receptors in Human Breast Carcinomas

Farrokh Dehdashti, Andrea H. McGuire, Henry F. Van Brocklin, Barry A. Siegel, Dorothy P. Andriole, Landis K. Griffeth, Martin G. Pomper, John A. Katzenellenbogen, Michael J. Welch

Journal of Nuclear Medicine Aug 1991, 32 (8) 1532-1537;

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Assessment of 21-[¹⁸F]Huoro-16α-Ethyl-19-Norprogesterone as a Positron-Emitting Radiopharmaceutical for the Detection of Progestin Receptors in Human Breast Carcinomas

Farrokh Dehdashti, Andrea H. McGuire, Henry F. Van Brocklin, Barry A. Siegel, Dorothy P. Andriole, Landis K. Griffeth, Martin G. Pomper, John A. Katzenellenbogen, Michael J. Welch

Journal of Nuclear Medicine Aug 1991, 32 (8) 1532-1537;

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Info & Metrics
PDF

No related articles found.

PubMed
Google Scholar

Cited By...

Imaging Diagnostic and Therapeutic Targets: Steroid Receptors in Breast Cancer
2-(3-{1-Carboxy-5-[(6-[18F]Fluoro-Pyridine-3-Carbonyl)-Amino]-Pentyl}-Ureido)-Pentanedioic Acid, [18F]DCFPyL, a PSMA-Based PET Imaging Agent for Prostate Cancer
Tumor Receptor Imaging

Google Scholar

Main menu

User menu

Search

Assessment of 21-[¹⁸F]Huoro-16α-Ethyl-19-Norprogesterone as a Positron-Emitting Radiopharmaceutical for the Detection of Progestin Receptors in Human Breast Carcinomas

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles